Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Haemonetics (HAE) Other Gross PP&E Adjustments (2017 - 2025)

Haemonetics has reported Other Gross PP&E Adjustments over the past 16 years, most recently at $824.5 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $824.5 million for Q4 2025, down 3.51% from a year ago — trailing twelve months through Dec 2025 was $824.5 million (down 3.51% YoY), and the annual figure for FY2025 was $837.2 million, down 12.72%.
  • Other Gross PP&E Adjustments for Q4 2025 was $824.5 million at Haemonetics, up from $790.4 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for HAE hit a ceiling of $967.1 million in Q4 2023 and a floor of $756.0 million in Q2 2025.
  • Median Other Gross PP&E Adjustments over the past 5 years was $889.3 million (2022), compared with a mean of $879.7 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: grew 8.64% in 2023 and later decreased 16.88% in 2025.
  • Haemonetics' Other Gross PP&E Adjustments stood at $817.3 million in 2021, then rose by 6.35% to $869.1 million in 2022, then rose by 11.27% to $967.1 million in 2023, then fell by 11.65% to $854.5 million in 2024, then dropped by 3.51% to $824.5 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $824.5 million (Q4 2025), $790.4 million (Q3 2025), and $756.0 million (Q2 2025) per Business Quant data.